Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of ArthroCare Corporation Stockholders

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP is investigating potential claims against the Board of Directors of ArthroCare Corporation (“ArthroCare” or the “Company”) (NASDAQ:ARTC) concerning the proposed acquisition of the Company by Smith & Nephew PLC (“Smith”) (NYSE:SNN). Under the terms of the definitive merger agreement, ArthroCare stockholders will receive $48.25 in cash for each share of ArthroCare owned, valuing the transaction at approximately $1.7 billion.